Screener
Fulgent Genetics, Inc. FLGT Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $71,138 | $73,463 |
| Cost of revenue | 49,648 | 45,117 |
| Gross profit | 21,490 | 28,346 |
| Operating expenses | ||
| Research and development | 14,176 | 12,395 |
| Selling and marketing | 12,221 | 8,465 |
| General and administrative | 27,684 | 25,291 |
| Amortization of intangible assets | 2,031 | 1,990 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s total cost of revenue?
- Fulgent Genetics, Inc. (FLGT) reported total cost of revenue of $49.65M in Q1 2026.
- How has Fulgent Genetics, Inc.'s total cost of revenue changed year-over-year?
- Fulgent Genetics, Inc.'s total cost of revenue increased by 10.0% year-over-year, from $45.12M to $49.65M.
- What is the long-term trend for Fulgent Genetics, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s total cost of revenue has grown at a -2.9% compound annual growth rate (CAGR), from $215.53M to $191.8M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Fulgent Genetics, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude